查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
旅游用疫苗的全球市场 - 产业规模，占有率，趋势，机会，预测:各组成，各疾病症状，各旅游类型，各地区(2017年～2027年)
市场调查报告书
商品编码
1152255

旅游用疫苗的全球市场 - 产业规模，占有率，趋势，机会，预测:各组成，各疾病症状，各旅游类型，各地区(2017年～2027年)

Travel Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Composition, By Disease Indication, By Travel Type and By Region
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球旅游用疫苗的市场规模，在预测期间内的2023年～2027年预计以稳定的速度成长。

由于流感发病率的上升，旅游观光类急速成长，市场成长。再加上为了防止特有种和跨国感染疾病预防意识高涨，及感染疾病增加的保健当局的严格建议、法规，也成为促进旅游用疫苗采用的要素。还有COVID-19大流行，为了防止感染扩大变得旅游用疫苗受到重视，一般市民对感染疾病扩大的认识和警戒高涨，旅游用疫苗的需求预计今后数年剧增。

本报告提供全球旅游用疫苗市场相关调查分析，各市场区隔、各地区的市场规模、占有率预测，市场动态，企业简介等系统性资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 摘要整理

第4章 COVID-19对全球旅游用疫苗市场的影响

第5章 VOC(客户的迴响)

  • 旅游用疫苗的关注
  • 旅游用疫苗:各地区
  • 旅游用疫苗:各旅游类型

第6章 全球旅游用疫苗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各组成(单剂疫苗和混合疫苗)
    • 各疾病症状(A型肝炎，DPT，黄热病，伤寒症，B型肝炎，麻疹、腮腺炎感冒，狂犬病(恐水症)，脑膜炎，水痘，日本脑炎，其他)
    • 各旅游类型(国内和海外)
    • 各地区
  • 产品市场地图

第7章 北美的旅游用疫苗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各组成
    • 各疾病症状
    • 各旅游类型
    • 各国
  • 北美:各国分析
    • 美国
    • 墨西哥
    • 加拿大

第8章 欧洲的旅游用疫苗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各组成
    • 各疾病症状
    • 各旅游类型
    • 各国
  • 欧洲:各国分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第9章 亚太地区的旅游用疫苗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各组成
    • 各疾病症状
    • 各旅游类型
    • 各国
  • 亚太地区:各国分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 新加坡

第10章 南美的旅游用疫苗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各组成
    • 各疾病症状
    • 各旅游类型
    • 各国
  • 南美:各国分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 中东、非洲的旅游用疫苗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各组成
    • 各疾病症状
    • 各旅游类型
    • 各国
  • MEA:各国分析
    • 南非
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 土耳其

第12章 市场动态

  • 促进因素
  • 课题

第13章 市场趋势与开发

第14章 竞争情形

  • GlaxoSmithKline, plc.
  • Sanofi S.A.
  • Novartis International AG
  • Merck KGaA
  • Pfizer Inc.
  • AstraZeneca Plc.
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • CSL Limited
  • Johnson & Johnson

第15章 策略性建议

简介目录
Product Code: 12838

The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of flu and rapid growth in the travel and tourism sector. Travel vaccines, also known as travel immunizations, are vaccine shots that protect travelers from serious illnesses. Vaccines work by exposing the body to germs of the disease it will protect against by enabling the production of antibodies. Besides, increasing awareness regarding the prevention of endemics and transnational infections and stringent advisories and regulations by health authorities to prevent the rise of infectious diseases are some of the factors driving the adoption of travel vaccines. The travel and tourism industry has witnessed a robust growth in recent years with the rise in disposable income of middle-class population across the world. Moreover, increasing trend of exploring different cultures, traditions, spiritualism, rural and ethnic living is propelling the adoption of travel vaccines. The COVID-19 pandemic has led to an increased emphasis on travel vaccines to avoid the spread of infections. As the public is becoming more aware and alert around the spread of infectious diseases, the demand for travel vaccine is expected to proliferate in the coming years. Growth in tourism activities have also led to the booming travel vaccine business for market players.

Stringent Advisories and Regulations by Health Authorities to Aid the Market Growth

Vaccination for diseases mentioned in the United States Department of Health & Human Services such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever is considered mandatory by some countries. These countries ask for mandatory vaccination proofs documented on an International Certification of Vaccination or Prophylaxis (ICVP) from travelers entering their country. Various countries' governments have implemented policies to prevent traveling citizens from travel-related infections. For instance, the National Health Services (NHS) organizes routine vaccination drives to prevent infectious diseases such as hepatitis A, typhoid, measles, mumps, yellow fever, among others. In addition, travelers coming for Hajj and Umrah in Saudi Arabia from various countries are required to show proof of vaccination for meningitis and seasonal influenza. Major countries such as the United States, Canada, Mexico, United Kingdom, Saudi Arabia, India, China, Japan, and Germany, among others, recommend travelers to be vaccinated for DPT. Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.

High Market Growth Potential in Emerging Nations

Rising personal disposable income of middle-class population in developing nations, owing to improving economic conditions, is increasing demand for travel and tourism. Travel and tourism is rapidly becoming a part of lifestyle for people in developing nations. Besides, growing awareness among population regarding various infections and disease that they could fall prey to while travelling to another country is boosting the travel vaccine market growth. Moreover, governments in developing regions are taking initiatives to create more awareness regarding infectious diseases, which is expected to fuel the growth of travel vaccines in the coming years.

Market Segmentation

The global travel vaccine market is segmented by composition, disease indication, travel type, and region. Based on composition, the market is divided into mono vaccines and combination vaccine. Based on disease indication, the market is divided into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and others. Based on travel type, the market is bifurcated into domestic and international. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is expected to hold a significant share in the global travel vaccine market, owing to rising incidences of infectious diseases and increased spending by population on travelling in the region.

Market Players

Key players operating in the global travel vaccine market are: GlaxoSmithKline, plc., Sanofi S.A., Novartis International AG, Merck KGaA, Pfizer Inc., AstraZeneca Plc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, CSL Limited, Johnson & Johnson, among others.

Report Scope:

In this report, the global travel vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Travel Vaccine Market, By Composition:

  • Mono Vaccines
  • Combination Vaccines

Travel Vaccine Market, By Disease Indication:

  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others

Travel Vaccine Market, By Type:

  • Domestic
  • International

Travel Vaccine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Singapore
    • South Korea
  • Europe & CIS
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • Israel
    • UAE
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global travel vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Travel Vaccine Market

5. Voice of Customer

  • 5.1. Travel Vaccination Awareness
  • 5.2. Travel Vaccination, By Region
  • 5.3. Travel Vaccination, By Travel Type

6. Global Travel Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Composition (Mono Vaccines v/s Combination Vaccines)
    • 6.2.2. By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)
    • 6.2.3. By Travel Type (Domestic v/s International)
    • 6.2.4. By Region
  • 6.3. Product Market Map

7. North America Travel Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Composition
    • 7.2.2. By Disease Indication
    • 7.2.3. By Travel Type
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Travel Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Composition
        • 7.3.1.2.2. By Disease Indication
        • 7.3.1.2.3. By Travel Type
    • 7.3.2. Mexico Travel Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Composition
        • 7.3.2.2.2. By Disease Indication
        • 7.3.2.2.3. By Travel Type
    • 7.3.3. Canada Travel Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Composition
        • 7.3.3.2.2. By Disease Indication
        • 7.3.3.2.3. By Travel Type

8. Europe Travel Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Composition
    • 8.2.2. By Disease Indication
    • 8.2.3. By Travel Type
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Travel Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Composition
        • 8.3.1.2.2. By Disease Indication
        • 8.3.1.2.3. By Travel Type
    • 8.3.2. Germany Travel Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Composition
        • 8.3.2.2.2. By Disease Indication
        • 8.3.2.2.3. By Travel Type
    • 8.3.3. United Kingdom Travel Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Composition
        • 8.3.3.2.2. By Disease Indication
        • 8.3.3.2.3. By Travel Type
    • 8.3.4. Italy Travel Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Composition
        • 8.3.4.2.2. By Disease Indication
        • 8.3.4.2.3. By Travel Type
    • 8.3.5. Spain Travel Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Composition
        • 8.3.5.2.2. By Disease Indication
        • 8.3.5.2.3. By Travel Type

9. Asia-Pacific Travel Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Composition
    • 9.2.2. By Disease Indication
    • 9.2.3. By Travel Type
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Travel Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Composition
        • 9.3.1.2.2. By Disease Indication
        • 9.3.1.2.3. By Travel Type
    • 9.3.2. India Travel Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Composition
        • 9.3.2.2.2. By Disease Indication
        • 9.3.2.2.3. By Travel Type
    • 9.3.3. South Korea Travel Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Composition
        • 9.3.3.2.2. By Disease Indication
        • 9.3.3.2.3. By Travel Type
    • 9.3.4. Japan Travel Vaccine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Composition
        • 9.3.4.2.2. By Disease Indication
        • 9.3.4.2.3. By Travel Type
    • 9.3.5. Australia Travel Vaccine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Composition
        • 9.3.5.2.2. By Disease Indication
        • 9.3.5.2.3. By Travel Type
    • 9.3.6. Singapore Travel Vaccine Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Composition
        • 9.3.6.2.2. By Disease Indication
        • 9.3.6.2.3. By Travel Type

10. South America Travel Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Composition
    • 10.2.2. By Disease Indication
    • 10.2.3. By Travel Type
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Travel Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Composition
        • 10.3.1.2.2. By Disease Indication
        • 10.3.1.2.3. By Travel Type
    • 10.3.2. Argentina Travel Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Composition
        • 10.3.2.2.2. By Disease Indication
        • 10.3.2.2.3. By Travel Type
    • 10.3.3. Colombia Travel Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Composition
        • 10.3.3.2.2. By Disease Indication
        • 10.3.3.2.3. By Travel Type

11. Middle East and Africa Travel Vaccine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Composition
    • 11.2.2. By Disease Indication
    • 11.2.3. By Travel Type
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Travel Vaccine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Composition
        • 11.3.1.2.2. By Disease Indication
        • 11.3.1.2.3. By Travel Type
    • 11.3.2. Saudi Arabia Travel Vaccine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Composition
        • 11.3.2.2.2. By Disease Indication
        • 11.3.2.2.3. By Travel Type
    • 11.3.3. UAE Travel Vaccine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Composition
        • 11.3.3.2.2. By Disease Indication
        • 11.3.3.2.3. By Travel Type
    • 11.3.4. Israel Travel Vaccine Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Composition
        • 11.3.4.2.2. By Disease Indication
        • 11.3.4.2.3. By Travel Type
    • 11.3.5. Turkey Travel Vaccine Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Composition
        • 11.3.5.2.2. By Disease Indication
        • 11.3.5.2.3. By Travel Type

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

  • 14.1. GlaxoSmithKline, plc.
  • 14.2. Sanofi S.A.
  • 14.3. Novartis International AG
  • 14.4. Merck KGaA
  • 14.5. Pfizer Inc.
  • 14.6. AstraZeneca Plc.
  • 14.7. Abbott Laboratories, Inc.
  • 14.8. F. Hoffmann-La Roche AG
  • 14.9. CSL Limited
  • 14.10. Johnson & Johnson

15. Strategic Recommendations